SEC Filings | Madrigal Pharmaceuticals.

Filing date	Form	Description	View
October 06, 2015	4	Statement of changes in beneficial ownership of securities	0001179110-15-013895.pdf 0001179110-15-013895.rtf
October 06, 2015	4	Statement of changes in beneficial ownership of securities	0001179110-15-013897.pdf 0001179110-15-013897.rtf
October 06, 2015	4	Statement of changes in beneficial ownership of securities	0001179110-15-013896.pdf 0001179110-15-013896.rtf
October 06, 2015	4	Statement of changes in beneficial ownership of securities	0001179110-15-013898.pdf 0001179110-15-013898.rtf
October 14, 2015	CORRESP	CORRESP	0001104659-15-070558.pdf 0001104659-15-070558.rtf 0001104659-15-070558.xls
October 16, 2015	8-K	Report of unscheduled material events or corporate event	0001104659-15-071102.pdf 0001104659-15-071102.rtf 0001104659-15-071102.xls
October 16, 2015	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	0001047469-15-007907.pdf 0001047469-15-007907.rtf 0001047469-15-007907.xls
October 16, 2015	EFFECT	EFFECT	9999999995-15-002773.pdf 9999999995-15-002773.rtf
October 22, 2015	8-K	Report of unscheduled material events or corporate event	0001104659-15-072217.pdf 0001104659-15-072217.rtf 0001104659-15-072217.xls
October 29, 2015	SC 13D/A	An amendment to a SC 13D filing	0000919574-15-007531.pdf 0000919574-15-007531.rtf 0000919574-15-007531.xls

Data provided by Kaleidoscope.